Estrogenic substance and Keloids - a phase IV clinical study of FDA data


Keloids is reported only by a few people who take Estrogenic Substance.

The phase IV clinical study analyzes which people take Estrogenic substance and have Keloids. It is created by eHealthMe based on reports of 791 people who have side effects while taking Estrogenic substance from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

791 people reported to have side effects when taking Estrogenic substance.
Among them, 3 people (0.38%) have Keloids.

What is Estrogenic substance?

Estrogenic substance has active ingredients of estrone. It is often used in menopause. eHealthMe is studying from 865 Estrogenic substance users for its effectiveness, alternative drugs and more.

What is Keloids?

Keloids (overgrown scars left from skin injuries) is found to be associated with 629 drugs and 446 conditions by eHealthMe.

Number of Estrogenic substance and Keloids reports submitted per year:

Could Estrogenic substance cause Keloids?

Gender of people who have Keloids when taking Estrogenic substance *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Keloids when taking Estrogenic substance *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Estrogenic substance *:

  1. Skelaxin: 3 people, 100.00%
  2. Motrin: 3 people, 100.00%
  3. Mobic: 3 people, 100.00%
  4. Meclizine: 3 people, 100.00%
  5. Avonex: 3 people, 100.00%

Common side effects people have besides Keloids *:

  1. Tendon Disorder (disease of tendon): 3 people, 100.00%
  2. Limb Deformity (functional disability of leg): 3 people, 100.00%
  3. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 100.00%
  4. Haematocrit Decreased: 3 people, 100.00%
  5. Femur Fracture: 3 people, 100.00%
  6. Device Dislocation: 3 people, 100.00%
  7. Clostridial Infection (infectious conditions by clostridium bacteria): 3 people, 100.00%
  8. Bone Deformity: 3 people, 100.00%
  9. Impaired Healing: 1 person, 33.33%

Common conditions people have *:

  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 100.00%
  2. Muscle Spasms (muscle contraction): 3 people, 100.00%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 100.00%
  4. Joint Pain: 3 people, 100.00%
  5. Dizziness: 3 people, 100.00%
  6. Birth Control: 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Estrogenic substance and have Keloids?

Check whether Keloids is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Keloids and when was it recovered:

Expand to all the drugs that have ingredients of estrone:

Alternative drugs to, pros and cons of Estrogenic substance:

Keloids treatments and more:

COVID vaccines that are related to Keloids:

All the drugs that are associated with Keloids:

All the conditions that are associated with Keloids:

How the study uses the data?

The study uses data from the FDA. It is based on estrone (the active ingredients of Estrogenic substance) and Estrogenic substance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: